Clinical Trial Update: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating NNC0487-0111 for weight loss and knee OA pain reduction in adults with obesity and knee osteoarthritis; currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Obesity

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Knee Osteoarthritis (OA) | Phase 3 | Status: RECRUITING